Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Azacitidine, sold under the brand name Vidaza among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia. It is a chemical analog of cytidine, a nucleoside in DNA and RNA.[medical citation needed] Azacitidine and its deoxy derivative, decitabine (also known as…
The analysis highlights Applications and Research as prominent areas in the source structure around Azacitidine.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Azacitidine shows recurring relationship patterns in the source. For example, Azacitidine → Clinical, ClinicalTrials, Diagnosed Advanced Myelodysplastic Syndrome, JMML, Juvenile Myelomonocytic Leukemia, MDS, NCT02447666, Pediatric Subjects With Newly, Study With Azacitidine Another extracted example is Azacitidine → After, As, Azacytosine-guanine, DNA, In, The, This. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
dna patients treatment also leukemia rna juvenile myelomonocytic methylation may myelodysplastic syndrome effects cell used inhibition toxicity medical cytidine decitabine
TTTA extracted 68 structured relationships around Azacitidine. Examples in this analysis include Azacitidine → 3D model (JSmol) → Interactive image and Azacitidine → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Azacitidine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Azacitidine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Azacitidine | ATC code | L01BC07 (WHO) | 1.00 | infobox |
| Azacitidine | CAS Number | 320-67-2 Y | 1.00 | infobox |
| Azacitidine | ChEBI | CHEBI:2038 Y | 1.00 | infobox |
| Azacitidine | ChEMBL | ChEMBL1489 Y | 1.00 | infobox |
| Azacitidine | ChemSpider | 9072 Y | 1.00 | infobox |
| Azacitidine | CompTox Dashboard (EPA) | DTXSID9020116 | 1.00 | infobox |
| Azacitidine | DrugBank | DB00928 Y | 1.00 | infobox |
| Azacitidine | ECHA InfoCard | 100.005.711 | 1.00 | infobox |
| Azacitidine | Elimination half-life | 4 hr. | 1.00 | infobox |
| Azacitidine | Formula | C8H12N4O5 | 1.00 | infobox |
| Azacitidine | IUPHAR/BPS | 6796 | 1.00 | infobox |
| Azacitidine | KEGG | D03021 Y | 1.00 | infobox |
| Azacitidine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Azacitidine | Legal status | CA: ℞-only | 1.00 | infobox |
| Azacitidine | Legal status | US: ℞-only | 1.00 | infobox |
| Azacitidine | Legal status | EU: Rx-only | 1.00 | infobox |
| Azacitidine | License data | US DailyMed: Azacitidine | 1.00 | infobox |
| Azacitidine | MedlinePlus | a607068 | 1.00 | infobox |
| Azacitidine | Molar mass | 244.207 g·mol−1 | 1.00 | infobox |
| Azacitidine | Other names | 5-Azacytidine, Azacytidine, Ladakamycin, 4-Amino-1-β-D-ribofuranosyl-s-triazin-2(1H)-one, U-18496, CC-486 | 1.00 | infobox |
| Azacitidine | Pregnancy category | AU: X (High risk) | 1.00 | infobox |
| Azacitidine | PubChem CID | 9444 | 1.00 | infobox |
| Azacitidine | Routes of administration | Subcutaneous, intravenous, by mouth | 1.00 | infobox |
| Azacitidine | Trade names | Vidaza, Azadine, Onureg | 1.00 | infobox |
| Azacitidine | UNII | M801H13NRU | 1.00 | infobox |
| Azacitidine | is a | ribonucleoside | 0.90 | text |
The concept neighborhoods around Azacitidine bring nearby vocabulary together. In this analysis, examples include Patients, Also and Treatment. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Azacitidine, one of the stronger structural bridges in this analysis connects Azacitidine with Toxicity. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Azacitidine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Azacitidine · EN edition · Analysis: TopicsToTalkAbout